Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS9531 for Weight Regain Control
NCT06287437Phase 2Active, not recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2024
- Primary completion
- Jun 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS9531 in obesity, sponsored by Zhongshan Hospital, Fudan University. Started Jan 2024; status: active, not recruiting.
02
Drugs
HRS9531
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06287437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06287437.